Mayne Pharma growth strategy in Women’s health - ASX SMIDcaps Conference
Corroborated by 1 source from 1 publisher
globalhealth1d ago
TL;DR
According to finance.yahoo.com, mayne Pharma Group Limited CEO Aaron Gray talked with Jonathan Jackson from Proactive at the Small and Mid-Cap Conference about the company’s strategy, product portfolio, and recent H1 results, highlighting its focus on women’s health and dermatology markets in the United States.